What Key Growth Drivers Are Shaping The Implantable Cardioverter Defibrillators (ICDs) Market Forecast Toward $4.95 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Implantable Cardioverter Defibrillators (ICDs) Market Today And What Is Its Future Size?
There has been a robust growth in the market size of implantable cardioverter defibrillators (ICDs) in the past few years. The market, which is projected to expand from a size of $3.76 billion in 2024 to $3.98 billion in 2025, is predicted to see a compound annual growth rate (CAGR) of 5.8%. This growth during the historical period can be tied to several factors such as the rising prevalence of sudden cardiac arrest, the inclusion of implantable defibrillator use in the secondary prevention of sudden cardiac arrest, enhanced public awareness, an increase in the elderly population, favorable policies from governments and healthcare organizations, along with improved healthcare access.
The market size for implantable cardioverter defibrillators (icds) is projected to display substantial growth in the coming years, with an estimated worth of $4.95 billion in 2029 and a compounded annual growth rate (CAGR) of 5.6%. This anticipated expansion during the forecast period is linked to the increasing acceptance of implantable defibrillators, heightened demand for tailored cardiac care, a growing rate of cardiac rhythm disorders, and escalated demand in emergent markets. Key trends for the forecast period encompass technological progressions, the launch of subcutaneous ICD that sidestep transvenous leads, increased demand for combined ICD devices with pacemaker capabilities, improvements in sensing and detection algorithms, ongoing developments in wireless charging and battery technology, and the incorporation of artificial intelligence (AI) in healthcare and data analytics.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20839&type=smp
Which Demand Drivers Are Strengthening The Implantable Cardioverter Defibrillators (ICDs) Market?
The rise in cardiovascular diseases (CVDs) is anticipated to fuel the expansion of the implantable cardioverter defibrillators (ICDs) market. CVDs comprise a variety of disorders that impact the heart and vascular system, including conditions like heart failure, stroke, and hypertension, often stemming from factors such as unhealthy eating habits, sedentary lifestyle, tobacco consumption, and hereditary reasons. The escalation in CVDs is largely due to older demographics, poor lifestyle selections, and the increasing incidence of health risks, including obesity, diabetes, and hypertension. ICDs contribute to the management of CVDs by delivering critical electric shocks to reinstate regular cardiac rhythms in individuals susceptible to sudden heart failure. According to the Australian Institute of Health and Welfare, a government agency based in Australia, the doctors’ verified deaths due to coronary heart disease (CHD) surged to 14,100 in 2021, and further increased to 14,900 in 2022. Thus, the rising prevalence of cardiovascular diseases (CVDs) is propelling the implantable cardioverter defibrillators (ICDs) market’s growth.
Which Segment Accounts For The Largest Share In The Implantable Cardioverter Defibrillators (ICDs) Market?
The implantable cardioverter defibrillators (icds)market covered in this report is segmented –
1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs); Dual Chamber Implantable Cardioverter Defibrillators (ICDs); Biventricular Devices
2) By Applications: Bradycardia; Tachycardia; Heart Failure; Other Applications
3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs; MRI-Compatible Single Chamber ICDs; Wireless Single Chamber ICDs
2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs; MRI-Compatible Dual Chamber ICDs; Wireless Dual Chamber ICDs
3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator); CRT-P (Cardiac Resynchronization Therapy Pacemaker); Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)
Which Long-Term Trends Will Play A Crucial Role In The Implantable Cardioverter Defibrillators (ICDs) Market?
The main players in the implantable cardioverter defibrillators (ICDs) sector are concentrating on technological improvements, such as defibrillators with low energy consumption, to boost device performance, increase battery life, and elevate patient comfort levels. These type of defibrillators aim at providing heart shocks using reduced energy, allowing battery longevity and ensuring effective arrhythmias treatment. For instance, MicroPort CRM, a medical devices firm based in France, launched the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan in October 2023. This marked a significant step in cardiac care technology. The devices offer advanced features like low energy consumption for extended battery longevity and MRI compatibility, making them ideal for patients requiring imaging procedures. The ULYS ICD comprises the PARAD+ arrhythmia differentiation algorithm and AutoMRI functionality, which increases patient safety during MRI scans. Additionally, the INVICTA lead exhibited a 100% successful implantation rate and a 97.4% rate of freedom from complications in clinical trials, illustrating its trustworthiness and effectiveness.
Which Companies Hold A Competitive Edge In The 1263 Market?
Major companies operating in the implantable cardioverter defibrillators (ICDs) market are Abbott Laboratories, Medtronic Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., LivaNova PLC, MicroPort Scientific Corporation, Japan Lifeline Co. Ltd., AtriCure Inc., Physio-Control Inc., BPL Medical Technologies Private Limited, Kestra Medical Technologies Inc., CU Medical Germany GmbH, Metrax GmbH, Intermedics Inc., Sorin Group S.p.A.
Access The Complete Report Here:
Which Region Is Forecasted To Lead The Implantable Cardioverter Defibrillators (ICDs) Market In The Coming Years?
North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardioverter defibrillators (ICDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=20839&type=smp
Browse Through More Reports Similar to the Global Implantable Cardioverter Defibrillators (ICDs) Market 2025, By The Business Research Company
Implantable Defibrillators Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/implantable-defibrillators-global-market-report
Automated External Defibrillators Aed Global Market Report 2025
Implantable Infusion Pumps Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
